GSK

Ex-Glaxo CEO Witty joins Hatteras as venture partner
Fierce Biotech
Tue, 09/19/17 - 08:59 am
Pharma CEOs
GSK
Andrew Witty
Hatteras Venture Partners
GSK Loses Bid For New Trial in Attorney Suicide Case
Bloomberg Law
Mon, 09/18/17 - 06:19 pm
GSK
Paxil
suicide
antidepressants
GSK’s triple-med COPD inhaler wins recommendation for approval in EU
Drug Delivery Business News
Fri, 09/15/17 - 09:13 am
GSK
COPD
Trelegy Ellipta
Europe
GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on
Endpoints
Thu, 09/14/17 - 09:54 am
GSK
Pharma CEOs
Emma Walmsley
vaccines
Shingrix
Zostavax
shingles
Struggling in R&D, GSK lines up an FDA pitch on COPD with mixed data
Endpoints
Tue, 09/12/17 - 09:59 am
GSK
R&D
FDA
COPD
mepolizumab
Nucala
GSK, JnJ and Sanofi: potential buyers of Merck KGaA’s Consumer Health business
GoInPharma
Mon, 09/11/17 - 09:11 pm
GSK
JNJ
Sanofi
Merck KGaA
consumer health
M&A
Ramping back up on oncology, GSK takes an option on Adaptimmune’s TCR cancer drug
Endpoints
Thu, 09/7/17 - 09:41 am
GSK
oncology
Adaptimmune
TCR therapeutics
Empathy at work: GlaxoSmithKline extends Excedrin Migraine campaign to include sufferers on the job
Fierce Pharma
Wed, 09/6/17 - 08:41 pm
GSK
Excederin Migraine
migraines
drug ads
DTC ads
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
FDA
Mylan Labs
Herceptin
biosimilars
trastuzumab
Shingrix
GSK
Pfizer
Sutent
PTC Therapeutics
Translarna
Amgen
Allergan
Avastin
Upcoming events – GSK’s shingles panel and Axovant takes on Alzheimer’s
EP Vantage
Sat, 08/26/17 - 07:46 pm
GSK
shingles
vaccines
Shingrix
Axovant
Alzheimer's disease
intepirdine
GlaxoSmithKline, Propeller widen respiratory sensor collaboration for COPD edge
Fierce Pharma
Thu, 08/24/17 - 05:15 pm
GSK
Propeller Health
COPD
devices
Ellipta
Are Glaxo's Successful New Drugs Enough to Drive Growth?
Yahoo/Zacks.com
Wed, 08/23/17 - 10:14 pm
GSK
Triumeq
Tivicay
Anoro
Incruse
Menveo
Bexsero
Shingrix
Nucala
An analysis of 2017 first half for pharmaceutical industry
GoInPharma
Sat, 08/19/17 - 10:51 am
pharma industry
Pfizer
Sanofi
GSK
Roche
Celgene
Bristol-Myers Squibb
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
patents
AbbVie
Humira
Pfizer
Lipitor
Norvasc
GSK
Advair
Sanofi
Lantus
JNJ
Remicade
AstraZeneca
Crestor
Nexium
Amgen
Neulasta
Novartis
Diovan
The big revamp at GlaxoSmithKline R&D includes a new collaboration on AI
Endpoints
Wed, 08/16/17 - 10:23 am
GSK
R&D
artificial intelligence
GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up
Xconomy
Fri, 08/11/17 - 11:37 am
GSK
Ionis
familial amyloid polyneuropathy
RNA
inotersen
Pharma's giants, new and old, tell more tales than their numbers show
Fierce Pharma
Fri, 08/11/17 - 11:16 am
Big Pharma
JNJ
Pfizer
GSK
Roche
Novartis
Sanofi
Bristol-Myers Squibb
Mylan points finger at FDA for failure to win nods on Advair, Copaxone copies
Fierce Pharma
Fri, 08/11/17 - 10:55 am
Mylan Labs
FDA
Advair
Copaxone
generics
Teva Pharmaceutical
GSK
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
pharma stocks
Merck
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
GSK
Roche
Sanofi
Bayer
Novo Nordisk
Celgene
Biogen
AstraZeneca
GSK déjà vu: Time for a top-down switch as new CEO tries to conquer old R&D demons
Endpoints
Mon, 08/7/17 - 11:14 am
GSK
Emma Walmsley
Pharma CEOs
R&D

Pages